Zhejiang Jingxin Pharmaceutical Co Ltd (002020) — Financial Flexibility Index
Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Financial Flexibility Index of 0.11x as of September 2025. Free cash flow of CN¥263.19 Million (operating CF CN¥227.64 Million minus capex CN¥35.55 Million) represents 0% of total liabilities (CN¥2.29 Billion). Also explore net asset growth rate of Zhejiang Jingxin Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Jingxin Pharmaceutical Co Ltd Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for Zhejiang Jingxin Pharmaceutical Co Ltd across 24 annual periods. Check how strategically is Zhejiang Jingxin Pharmaceutical Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Jingxin Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Zhejiang Jingxin Pharmaceutical Co Ltd (002020) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | CN¥984.20 Million | CN¥781.35 Million | CN¥2.25 Billion | ▲ +10.8% |
| 2024 | 0.39x | CN¥976.81 Million | CN¥726.16 Million | CN¥2.48 Billion | ▼ -28.3% |
| 2023 | 0.55x | CN¥1.34 Billion | CN¥824.69 Million | CN¥2.45 Billion | ▼ -12.2% |
| 2022 | 0.63x | CN¥1.37 Billion | CN¥855.78 Million | CN¥2.19 Billion | ▲ +28.4% |
| 2021 | 0.49x | CN¥769.46 Million | CN¥365.02 Million | CN¥1.58 Billion | ▼ -0.2% |
| 2020 | 0.49x | CN¥847.21 Million | CN¥513.21 Million | CN¥1.73 Billion | ▲ +7.2% |
| 2019 | 0.46x | CN¥872.64 Million | CN¥535.30 Million | CN¥1.91 Billion | ▼ -15.6% |
| 2018 | 0.54x | CN¥765.60 Million | CN¥523.40 Million | CN¥1.42 Billion | ▲ +1.9% |
| 2017 | 0.53x | CN¥497.20 Million | CN¥385.01 Million | CN¥938.43 Million | ▲ +31.6% |
| 2016 | 0.40x | CN¥347.96 Million | CN¥252.69 Million | CN¥864.23 Million | ▲ +5.6% |
| 2015 | 0.38x | CN¥259.00 Million | CN¥144.69 Million | CN¥679.39 Million | ▼ -16.8% |
| 2014 | 0.46x | CN¥305.23 Million | CN¥210.49 Million | CN¥666.12 Million | ▲ +5.9% |
| 2013 | 0.43x | CN¥219.31 Million | CN¥111.03 Million | CN¥506.65 Million | ▲ +59.1% |
| 2012 | 0.27x | CN¥143.79 Million | CN¥60.28 Million | CN¥528.40 Million | ▼ -17.9% |
| 2011 | 0.33x | CN¥141.27 Million | CN¥69.41 Million | CN¥426.39 Million | ▼ -3.3% |
| 2010 | 0.34x | CN¥215.42 Million | CN¥59.55 Million | CN¥629.02 Million | ▲ +34.3% |
| 2009 | 0.25x | CN¥155.56 Million | CN¥135.38 Million | CN¥610.06 Million | ▲ +124.6% |
| 2008 | 0.11x | CN¥73.80 Million | CN¥29.98 Million | CN¥649.89 Million | ▲ +348.3% |
| 2007 | -0.05x | CN¥-32.75 Million | CN¥-87.60 Million | CN¥716.18 Million | ▼ -124.3% |
| 2006 | 0.19x | CN¥89.86 Million | CN¥-1.45 Million | CN¥478.23 Million | ▼ -73.3% |
| 2005 | 0.70x | CN¥196.49 Million | CN¥61.82 Million | CN¥279.27 Million | ▲ +21.9% |
| 2004 | 0.58x | CN¥104.54 Million | CN¥6.43 Million | CN¥181.11 Million | ▼ -16.2% |
| 2003 | 0.69x | CN¥117.37 Million | CN¥46.18 Million | CN¥170.36 Million | ▼ -11.9% |
| 2002 | 0.78x | CN¥93.29 Million | CN¥45.50 Million | CN¥119.35 Million | — |